A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia

Sanie Sesay, Paul Milligan, Ensa Touray, Maimuna Sowe, Emily L Webb, Brian M Greenwood, Kalifa A Bojang, Sanie Sesay, Paul Milligan, Ensa Touray, Maimuna Sowe, Emily L Webb, Brian M Greenwood, Kalifa A Bojang

Abstract

Background: Individual malaria interventions provide only partial protection in most epidemiological situations. Thus, there is a need to investigate whether combining interventions provides added benefit in reducing mortality and morbidity from malaria. The potential benefits of combining IPT in children (IPTc) with home management of malaria (HMM) was investigated.

Methods: During the 2008 malaria transmission season, 1,277 children under five years of age resident in villages within the rural Farafenni demographic surveillance system (DSS) in North Bank Region, The Gambia were randomized to receive monthly IPTc with a single dose of sulphadoxine/pyrimethamine (SP) plus three doses of amodiaquine (AQ) or SP and AQ placebos given by village health workers (VHWs) on three occasions during the months of September, October and November, in a double-blind trial. Children in all study villages who developed an acute febrile illness suggestive of malaria were treated by VHWs who had been taught how to manage malaria with artemether-lumefantrine (Coartem™). The primary aims of the project were to determine whether IPTc added significant benefit to HMM and whether VHWs could effectively combine the delivery of both interventions.

Results: The incidence of clinical attacks of malaria was very low in both study groups. The incidence rate of malaria in children who received IPTc was 0.44 clinical attacks per 1,000 child months at risk while that for control children was 1.32 per 1,000 child months at risk, a protective efficacy of 66% (95% CI -23% to 96%; p = 0.35). The mean (standard deviation) haemoglobin concentration at the end of the malaria transmission season was similar in the two treatment groups: 10.2 (1.6) g/dL in the IPTc group compared to 10.3 (1.5) g/dL in the placebo group. Coverage with IPTc was high, with 94% of children receiving all three treatments during the study period.

Conclusion: Due to the very low incidence of malaria, no firm conclusion can be drawn on the added benefit of IPTc in preventing clinical episodes of malaria among children who had access to HMM in The Gambia. However, the study showed that VHWs can successfully combine provision of HMM with provision of IPTc.

Trial registration: ClinicalTrials.gov NCT00944840.

Figures

Figure 1
Figure 1
Trial profile. * The remaining children were not studied because they did not meet the inclusion criteria, no consent was given or had one of the exclusion criteria

References

    1. Greenwood BM. Control to elimination: implications for malaria research. Trends Parasitol. 2008;24:449–454. doi: 10.1016/j.pt.2008.07.002.
    1. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomized placebo-controlled trial. Lancet. 1999;353:632–636. doi: 10.1016/S0140-6736(98)07318-8.
    1. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux ME. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg. 2000;94:549–553. doi: 10.1016/S0035-9203(00)90083-X.
    1. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet. 2009;374:1533–1542. doi: 10.1016/S0140-6736(09)61258-7.
    1. WHO. Technical Consultation on Intermittent Preventive Treatment of Infants (IPTi) Geneva, Switzerland: WHO; 2009.
    1. Etard JF, Le Hesran JY, Diallo A, Diallo JP, Ndiaye JL, Delaunay V. Childhood mortality and probable causes of death using verbal autopsy in Niakhar, Senegal, 1989-2000. Int J Epidemiol. 2004;33:1286–1292. doi: 10.1093/ije/dyh259.
    1. Jaffar S, Leach A, Greenwood AM, Jepson A, Muller O, Ota MO, Bojang K, Obaro S, Greenwood BM. Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Trop Med Int Health. 1997;2:28–37. doi: 10.1046/j.1365-3156.1997.d01-131.x.
    1. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ, Sesay SS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T, Bojang KA, Whittle HC, Greenwood BM, Conway DJ. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet. 2008;372:1545–1554. doi: 10.1016/S0140-6736(08)61654-2.
    1. Cissé B, Sokhna C, Boulanger D, Milet J, Bâel H, Richardson K, Hallett R, Sutherland C, Simondon K, Simondon F, Alexander N, Gaye O, Targett G, Lines J, Greenwood B, Trape JF. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, doubleblind trial. Lancet. 2006;367:659–667.
    1. Dicko A, Sagara I, Sissoko MS, Guindo O, Diallo AI, Kone M, Toure OB, Sacko M, Doumbo OK. Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J. 2008;7:123. doi: 10.1186/1475-2875-7-123.
    1. Kweku M, Liu D, Adjuik M, Binka F, Seidu M, Greenwood B, Chandramohan D. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS ONE. 2008;3:e4000. doi: 10.1371/journal.pone.0004000.
    1. Nsabagasani X, Sabiiti Jesca Nsungwa, Källander K, Peterson S, Pariyo G, Tomson G. : Home-based management of fever in rural Uganda: community perceptions and provider opinions. Malar J. 2007;6:11. doi: 10.1186/1475-2875-6-11.
    1. World Health Organization. The Roll Back Malaria Strategy for Improving Access to Treatment through Home Management of malaria. 2005. p. 1101. WHO/HTM/MAL/
    1. Sirima SB, Konate A, Tiono AB, Convelbo N, Cousens S, Pagnoni F. Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health. 2003;8:133–139. doi: 10.1046/j.1365-3156.2003.00997.x.
    1. Kidane G, Morrow RH. Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial. Lancet. 2000;356:550–555. doi: 10.1016/S0140-6736(00)02580-0.
    1. WHO. Scaling up home-based management of malaria: from research to implementation. Geneva, World Health Organization; 2004.
    1. Hopkins H, Talisuna A, Whitty CJ, Staedke SG. Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. Malar J. 2007;6:134. doi: 10.1186/1475-2875-6-134.
    1. Ahorlu CK, Koram KA, Seakey AK, Weiss MG. Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control. Malar J. 2009;8:292. doi: 10.1186/1475-2875-8-292.
    1. INDEPTH Network.
    1. Greenwood BM, Pickering H. A review of the epidemiology and control of malaria in The Gambia, West Africa. Trans R Soc Trop Med Hyg. 1993;87(suppl 2):3–11. doi: 10.1016/0035-9203(93)90169-Q.
    1. INDEPTH Network. Population and health in developing countries: Volume 1: Population, health, and survival at INDEPTH sites. Ottawa, Canada: International Development Research Centre; 2002.
    1. O'Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10:545–55.
    1. Dicko A, Diallo AI, Tembine I, Dicko Y, Dara N, Sidibe Y, Santara G, Diawara H, Konaré T, Djimde A, Chandramohan D, Cousens S, Milligan P, Diallo D, K Doumbo OK, Greenwood BM. A randomised, placebo-controlled trial of intermittent preventive treatment of malaria with sulphadoxine -pyrimethamine plus amodiaquine in children protected by a long lasting insecticide treated net in Mali. PLOS Medicine. in press .
    1. Konaté AT, Yaro J-P, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, Kangoyé DT, Kaboré Y, Ouédraogo E, Ouédraogo A, Tiono T, Ouédraogo IN, Chandramohan D, Cousens S, Milligan P, Sirima SB, Greenwood BM, Diallo DA. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide treated bednet in Burkina Faso. PLOS Medicine. in press .

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner